- Global Campus as a Future Biocluster Hub November 23, 2023
-
Creating Global Impact through Convergence and Industry-Academia Collaboration
Yonsei University is striving to establish a new model for its university campus in Incheon Songdo International City. The goal is to create an innovative cluster focused on education, research, industry collaboration, and healthcare. Following the first phase of campus development, which was centered around education and globalization, Yonsei University is now proceeding with the second phase to establish the Yonsei Science Park (YSP) by creating various programs and establishing infrastructure to promote advanced research and academia-industry collaboration.
Recently, Yonsei University collaborated with the city of Incheon to successfully attract the main campus of the Ministry of Health and Welfare’s “Global Bio Campus Development Project” to its global campus. This project aims to train bio experts in low and middle-income countries and marks another significant achievement, following the successful attraction of the “K-NIBRT Project” and the “K-Bio Lab Hub Development Project.” Additionally, with the completion of the Songdo Severance Hospital, which aims to become the base hospital for bio commercialization, the Songdo Bio Cluster will make a significant leap forward.
K-NIBRT Project
This is a project launched in partnership with the National Institute for Bioprocessing Research and Training (NIBRT) in Ireland aimed at producing global biopharmaceuticals and vaccines while fostering specialized personnel needed for market expansion. The city of Incheon, Ministry of Health and Welfare, and Yonsei University formed a consortium, and Yonsei University assumed charge of the K-NIBRT education program. The program started in 2022, and a total of 881 Korean students have been trained through this program so far. Furthermore, in partnership with the Asian Development Bank (ADB), 59 students from developing countries have been provided with education, and as of October 2023, 36 students are currently undergoing training.
In June 2023, the groundbreaking ceremony for the “Bioprocess Workforce Center and Pharmaceutical Bio Practicalization Center” was held. Once the Bioprocess Workforce Center is completed by the end of 2024, the K-NIBRT training center will be moved to the Bioprocess Workforce Center to step up for education and training endeavors. Over 2,000 bioprocess experts will be cultivated annually, thereby addressing workforce imbalances.
K-Bio Lab Hub Development Project
The “K-Bio Lab Hub” project was launched by the Ministry of SMEs and Startups to foster bio startups to advance Korea as a bio powerhouse in the global community. This is the Korean version of the Boston Bio Cluster Project, where startups are supported from basic research to non-clinical and commercialization stages. The plan is to complete the construction of the project site within Yonsei University’s global campus by 2025, with full-scale operations commencing in 2026.
Yonsei University has also signed agreements with leading Korean pharmaceutical and bio companies, including Celltrion, Samsung Biologics, SK Bioscience, Yuhan Corporation, HK Inno.N, GC Green Cross, and Daewoong Pharmaceutical as well as global bio institutions, such as Moderna and Boston LabCentral, to promote collaboration between large corporations and startups for an open innovation-based growth.
Global Bio Campus Project
Recently, Yonsei University successfully attracted the main campus of the “WHO Global Bio Campus Development Project” to its global campus in collaboration with the city of Incheon. This project aims at fostering bio experts in developing countries in partnership with the World Health Organization (WHO) and is scheduled to start producing trained experts from 2024.
These achievements in attracting major national projects are the result of Yonsei University’s dedicated efforts to transform its global campus into the “Yonsei Science Park (Research and industry-academia innovation cluster).” With the completion of the Songdo Severance Hospital, it is expected to become a base hospital for bio industrialization with bio research capabilities. As a bio-industry hub hospital, it will serve as a K-Bio industry hub through clinical trials and bio-health convergence research.
-
SINCHON·INT′l
SINCHON·INT′l
- MIRAE
show mobile menu
mobile menu
